DATE,PATIENT,ENCOUNTER,CODE,DESCRIPTION,BASE_COST
2016-03-14T10:42:34Z,16723be3-6c7f-1ef0-5112-12f82e5ea6f4,0fe82460-fa92-75f7-f3fa-6e4ddbe21a81,140,Influenza  seasonal  injectable  preservative free,136.0
2016-03-14T10:42:34Z,16723be3-6c7f-1ef0-5112-12f82e5ea6f4,0fe82460-fa92-75f7-f3fa-6e4ddbe21a81,113,Td (adult)  5 Lf tetanus toxoid  preservative free  adsorbed,136.0
2016-03-14T10:42:34Z,16723be3-6c7f-1ef0-5112-12f82e5ea6f4,0fe82460-fa92-75f7-f3fa-6e4ddbe21a81,43,Hep B  adult,136.0
2016-03-14T10:42:34Z,16723be3-6c7f-1ef0-5112-12f82e5ea6f4,0fe82460-fa92-75f7-f3fa-6e4ddbe21a81,114,meningococcal MCV4P,136.0
2019-03-18T10:42:34Z,16723be3-6c7f-1ef0-5112-12f82e5ea6f4,a11ef50b-329b-7a19-d2b2-99532baf1e4b,140,Influenza  seasonal  injectable  preservative free,136.0
2021-04-19T10:42:34Z,16723be3-6c7f-1ef0-5112-12f82e5ea6f4,4dcf5bbe-6f42-d38d-1a55-bc89f4ec502d,207,COVID-19  mRNA  LNP-S  PF  100 mcg/0.5mL dose or 50 mcg/0.25mL dose,136.0
2021-05-17T10:42:34Z,16723be3-6c7f-1ef0-5112-12f82e5ea6f4,91e20ab4-877a-f2b3-c12a-0038840ee4bd,207,COVID-19  mRNA  LNP-S  PF  100 mcg/0.5mL dose or 50 mcg/0.25mL dose,136.0
2022-03-21T10:42:34Z,16723be3-6c7f-1ef0-5112-12f82e5ea6f4,50af8f88-5fd6-02f7-ce10-49dd40d417c5,140,Influenza  seasonal  injectable  preservative free,136.0
